Pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Parmax Pharma has informed that all activities in relation to both physical and electronic share transfer facility are maintained during the period of 1st October 2018 to 31st March, 2019 by the Company’s Registrar and Share Transfer Agent, Purva Sharegistry India, having its Office at Unit no. 9, Shiv Shakti Ind. Estt. J .R. Boricha Marg, Lower Parel (E), Mumbai 400 011. Further, the company confirmed that Purva Sharegistry India is registered as Permanent Category- I Registrar and Transfer Agent with the Securities and Exchange Board of India (SEBI Registration no. INR000001112).
The above information is a part of company’s filings submitted to BSE.